Literature DB >> 22653143

Huge recurrent tumoral calcinosis needing extensive excision and reconstruction: report of a rare case and brief literature review.

Efstathios G Lykoudis1, Konstantinos Seretis, Stavros Ristanis.   

Abstract

UNLABELLED: Tumoral calcinosis, a rare benign clinical condition resembling a neoplasm, is characterized by calcium deposits, usually located in the soft tissues around the large joints. It can be primary or secondary to renal failure and hyperparathyroidism. This report describes an unusual case of recurrent tumoral calcinosis presenting as a huge mass infiltrating the skin and muscles of the lumbosacral area. The patient underwent wide excision and reconstruction with bilateral V-Y advancement gluteal fasciocutaneous flaps and at this writing remains disease free 4 years postoperatively. A concise review of the pertinent literature focusing on the diagnosis, treatment options, and preventive measures also is reported. LEVEL OF EVIDENCE V: This journal requires that authors assign a level of evidence to each article.

Entities:  

Mesh:

Year:  2012        PMID: 22653143     DOI: 10.1007/s00266-012-9923-0

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  3 in total

Review 1.  Review of tumoral calcinosis: A rare clinico-pathological entity.

Authors:  Ibrahim Fathi; Mahmoud Sakr
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

Review 2.  Juxta-articular tumoral calcinosis associated with the temporomandibular joint: a case report and concise review.

Authors:  Yang Sha; Kanglun Hong; Melvin Kang Ming Liew; Jing Li Lum; Raymond Chung Wen Wong
Journal:  BMC Oral Health       Date:  2019-07-09       Impact factor: 2.757

3.  Multifocal tumoral calcinosis in a 4-year-old girl.

Authors:  Ilyas Sayar; Kemal Peker; Alparslan Kapısız; Isıl Esen Bostancı; Mehmet Gürbüzel; Arda Isik; Necla Aydın Peker
Journal:  Am J Case Rep       Date:  2014-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.